The mission of the group is to identify early-stage companies with disruptive technologies that solve unmet needs in biologic drug R&D and production, as well as challenges in the diagnostics market. Investment selection is completed thorough a rigorous review process, which starts with in-depth market work, followed by due diligence according to Danaher’s best-in-class standard work.

Danaher Ventures
danaher.comRelated companies
Here are more companies like Danaher Ventures.
Mass General Brigham Ventures
Our unique model combines first access and proprietary rights to disruptive deal flow with an established track record of new venture formation, company buildin…
Finchley Healthcare Ventures
With a passion for advancing healthcare and a keen focus on fostering innovation, FHCV is dedicated to supporting companies developing new and transformative me…
Bioqube Ventures
Bioqube Ventures is a specialist life sciences investment firm based in Europe and US with a global footprint. We source, finance and develop innovative therape…
Third Rock Ventures
When we founded the firm in 2007, our imaginations were on fire with the possibility of translating scientific discoveries to breakthrough medicines. Could we f…
Sanofi Ventures
We invest in the innovators behind the miracles of science who are passionate about improving human health. Sanofi Ventures serves as an entry point to the inno…
Cambrian Biopharma
Cambrian Biopharma, a multi-asset longevity biotech, is building the medicines that will redefine healthcare in the 21st century – therapeutics to lengthen heal…